Giannis Stoupis

Biochemistry, Genetics and Molecular Biology · Life Sciences

4h-index304citations11works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(9), Cancer Cells and Metastasis(8), MicroRNA in disease regulation(2), Cancer-related molecular mechanisms research(2), HER2/EGFR in Cancer Research(2)

Publications11 total

Table S1 from Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer
2023Open Access
Table S2 from Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer
2023Open Access
Data from Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer
2023Open Access
Table S1 from Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer
2023· 1 citedOpen Access
Table S2 from Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer
2023Open Access
Data from Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer
2023Open Access
Circulating microRNAs related to DNA damage response as predictors of survival in metastatic non- small cell lung cancer patients treated with platinum-based chemotherapy
Annals of Oncology·2019Open Access
Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
Oncotarget·2019· 47 citedOpen Access
Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer
Molecular Cancer Therapeutics·2018· 202 cited
Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer
Translational Oncology·2017· 9 citedOpen Access
A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer
Cellular Physiology and Biochemistry·2017· 45 citedOpen Access

Frequent Co-authors

Sofia Agelaki(10), Maria A. Papadaki(8), Vassilis Georgoulias(8), Panayiotis A. Theodoropoulos(7), Dimitris Mavroudis(7), Dimitriοs Mavroudis(4), Chara Papadaki(2), Alexia Monastirioti(2), Dora Hatzidaki(2), Leuteris Tsalikis(1), Neofytos Maliotis(1), Michalis Stratigos(1), Georgios Mastrostamatis(1), Eleni Politaki(1), Stella Apostolaki(1), Αreti Strati(1), Filippos Koinis(1), Maria Perraki(1), Georgia Saloustrou(1), Galatea Kallergi(1)